Literature DB >> 1688418

A new class of antivirals: antisense oligonucleotides combined with a hydrophobic substituent effectively inhibit influenza virus reproduction and synthesis of virus-specific proteins in MDCK cells.

A V Kabanov1, S V Vinogradov, A V Ovcharenko, A V Krivonos, N S Melik-Nubarov, V I Kiselev, E S Severin.   

Abstract

To enhance the penetration of oligonucleotide ('oligo') into cells, the oligo was combined with the hydrophobic undecyl residue. Using the 'DNA-synthesator', we synthesized oligo, complementary to the loop-forming site of the RNA, encoding polymerase 3 of the influenza virus (type A), and combined it with the undecyl residue added to the 5' terminal phosphate group. It was found that the modified oligo effectively suppresses the influenza A/PR8/34 (H1N1) virus reproduction and inhibits the synthesis of virus-specific proteins in MDCK cells. Under the same conditions, the non-modified antisense oligo and modified nonsense oligo did not affect the virus development.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1688418     DOI: 10.1016/0014-5793(90)80039-l

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  17 in total

1.  Synthesis and physical properties of anti-HIV antisense oligonucleotides bearing terminal lipophilic groups.

Authors:  C MacKellar; D Graham; D W Will; S Burgess; T Brown
Journal:  Nucleic Acids Res       Date:  1992-07-11       Impact factor: 16.971

Review 2.  Antigene, ribozyme and aptamer nucleic acid drugs: progress and prospects.

Authors:  R A Stull; F C Szoka
Journal:  Pharm Res       Date:  1995-04       Impact factor: 4.200

3.  Synthesis and hybridization properties of oligonucleotides containing 2'-O-modified ribonucleotides.

Authors:  T H Keller; R Häner
Journal:  Nucleic Acids Res       Date:  1993-09-25       Impact factor: 16.971

4.  Safety, tolerability, and pharmacokinetics of radavirsen (AVI-7100), an antisense oligonucleotide targeting influenza a M1/M2 translation.

Authors:  John H Beigel; Jocelyn Voell; Paula Muñoz; Parag Kumar; Kristina M Brooks; Jianbo Zhang; Patrick Iversen; Alison Heald; Michael Wong; Richard T Davey
Journal:  Br J Clin Pharmacol       Date:  2017-09-22       Impact factor: 4.335

Review 5.  Nucleoside, nucleotide and oligonucleotide based amphiphiles: a successful marriage of nucleic acids with lipids.

Authors:  Arnaud Gissot; Michel Camplo; Mark W Grinstaff; Philippe Barthélémy
Journal:  Org Biomol Chem       Date:  2008-03-05       Impact factor: 3.876

Review 6.  Targeting hepatitis B therapy to the liver. Clinical pharmacokinetic considerations.

Authors:  P C Rensen; R L de Vrueh; T J van Berkel
Journal:  Clin Pharmacokinet       Date:  1996-08       Impact factor: 6.447

7.  An anti-lymphocytic choriomeningitis virus ribozyme expressed in tissue culture cells diminishes viral RNA levels and leads to a reduction in infectious virus yield.

Authors:  Z Xing; J L Whitton
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

8.  Inhibition of influenza virus replication by phosphorothioate oligodeoxynucleotides.

Authors:  J M Leiter; S Agrawal; P Palese; P C Zamecnik
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

9.  Drug targeting: synthesis and endocytosis of oligonucleotide-neoglycoprotein conjugates.

Authors:  E Bonfils; C Depierreux; P Midoux; N T Thuong; M Monsigny; A C Roche
Journal:  Nucleic Acids Res       Date:  1992-09-11       Impact factor: 16.971

Review 10.  Reactive oligonucleotide derivatives as gene-targeted biologically active compounds and affinity probes.

Authors:  D G Knorre; V V Vlassov
Journal:  Genetica       Date:  1991       Impact factor: 1.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.